Literature DB >> 21098268

Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits.

Robert Tamayev1, Shuji Matsuda, Mauro Fà, Ottavio Arancio, Luciano D'Adamio.   

Abstract

According to the prevailing "amyloid cascade hypothesis," genetic dementias such as Alzheimer's disease and familial Danish dementia (FDD) are caused by amyloid deposits that trigger tauopathy, neurodegeneration, and behavioral/cognitive alterations. To efficiently reproduce amyloid lesions, murine models of human dementias invariably use transgenic expression systems. However, recent FDD transgenic models showed that Danish amyloidosis does not cause memory defects, suggesting that other mechanisms cause Danish dementia. We studied an animal knock-in model of FDD (FDD(KI/+)) genetically congruous with human cases. FDD(KI/+) mice present reduced Bri2 levels, impaired synaptic plasticity and severe hippocampal memory deficits. These animals show no cerebral lesions that are reputed characteristics of human dementia, such as tangles or amyloid plaques. Bri2(+/-) mice exhibit synaptic and memory deficits similar to FDD(KI/+) mice, and memory loss of FDD(KI/+) mice is prevented by expression of WT BRI2, indicating that Danish dementia is caused by loss of BRI2 function. Together, the data suggest that clinical dementia in Danish patients occurs via a loss of function mechanism and not as a result of amyloidosis and tauopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098268      PMCID: PMC2996452          DOI: 10.1073/pnas.1011689107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

2.  A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.

Authors:  R Vidal; T Revesz; A Rostagno; E Kim; J L Holton; T Bek; M Bojsen-Møller; H Braendgaard; G Plant; J Ghiso; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  Exposing rats to a predator impairs spatial working memory in the radial arm water maze.

Authors:  D M Diamond; C R Park; K L Heman; G M Rose
Journal:  Hippocampus       Date:  1999       Impact factor: 3.899

Review 4.  Learning and memory in transgenic mice modeling Alzheimer's disease.

Authors:  K H Ashe
Journal:  Learn Mem       Date:  2001 Nov-Dec       Impact factor: 2.460

5.  Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.

Authors:  Ganesh M Shankar; Shaomin Li; Tapan H Mehta; Amaya Garcia-Munoz; Nina E Shepardson; Imelda Smith; Francesca M Brett; Michael A Farrell; Michael J Rowan; Cynthia A Lemere; Ciaran M Regan; Dominic M Walsh; Bernardo L Sabatini; Dennis J Selkoe
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

Review 6.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

7.  BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2.

Authors:  Shuji Matsuda; Yukiko Matsuda; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

8.  Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.

Authors:  Daniela Puzzo; Lucia Privitera; Elena Leznik; Mauro Fà; Agnieszka Staniszewski; Agostino Palmeri; Ottavio Arancio
Journal:  J Neurosci       Date:  2008-12-31       Impact factor: 6.167

9.  Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles.

Authors:  Shuji Matsuda; Yukiko Matsuda; Erik L Snapp; Luciano D'Adamio
Journal:  Neurobiol Aging       Date:  2009-09-12       Impact factor: 4.673

10.  Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2.

Authors:  Ruben Vidal; Ana G Barbeito; Leticia Miravalle; Bernardino Ghetti
Journal:  Brain Pathol       Date:  2008-04-10       Impact factor: 6.508

View more
  34 in total

1.  Tuning of Glutamate, But Not GABA, Release by an Intrasynaptic Vesicle APP Domain Whose Function Can Be Modulated by β- or α-Secretase Cleavage.

Authors:  Wen Yao; Marc D Tambini; Xinran Liu; Luciano D'Adamio
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

2.  BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells.

Authors:  M Del Campo; C R Oliveira; W Scheper; R Zwart; C Korth; A Müller-Schiffmann; G Kostallas; H Biverstal; J Presto; J Johansson; J J Hoozemans; C F Pereira; C E Teunissen
Journal:  Cell Mol Life Sci       Date:  2014-10-22       Impact factor: 9.261

3.  BRICHOS domains efficiently delay fibrillation of amyloid β-peptide.

Authors:  Hanna Willander; Jenny Presto; Glareh Askarieh; Henrik Biverstål; Birgitta Frohm; Stefan D Knight; Jan Johansson; Sara Linse
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

4.  Amyloid and intracellular accumulation of BRI2.

Authors:  Holly J Garringer; Neeraja Sammeta; Adrian Oblak; Bernardino Ghetti; Ruben Vidal
Journal:  Neurobiol Aging       Date:  2016-12-29       Impact factor: 4.673

5.  Increased expression of reticulon 3 in neurons leads to reduced axonal transport of β site amyloid precursor protein-cleaving enzyme 1.

Authors:  Minzi Deng; Wanxia He; Ya Tan; Hailong Han; Xiangyou Hu; Kun Xia; Zhuohua Zhang; Riqiang Yan
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

6.  The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.

Authors:  Beverly W Baron; Rebecca M Baron; Joseph M Baron
Journal:  Biochim Biophys Acta       Date:  2014-12-31

7.  BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE).

Authors:  Ellen Kilger; Anika Buehler; Heidrun Woelfing; Sathish Kumar; Stephan A Kaeser; Amudha Nagarathinam; Jochen Walter; Mathias Jucker; Janaky Coomaraswamy
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

8.  Increased AβPP processing in familial Danish dementia patients.

Authors:  Shuji Matsuda; Robert Tamayev; Luciano D'Adamio
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

9.  APP heterozygosity averts memory deficit in knockin mice expressing the Danish dementia BRI2 mutant.

Authors:  Robert Tamayev; Shuji Matsuda; Luca Giliberto; Ottavio Arancio; Luciano D'Adamio
Journal:  EMBO J       Date:  2011-05-17       Impact factor: 11.598

10.  Interaction of ApoE3 and ApoE4 isoforms with an ITM2b/BRI2 mutation linked to the Alzheimer disease-like Danish dementia: Effects on learning and memory.

Authors:  Fabrizio Biundo; Keita Ishiwari; Dolores Del Prete; Luciano D'Adamio
Journal:  Neurobiol Learn Mem       Date:  2015-10-31       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.